pI: 5.9131 |
Length (AA): 476 |
MW (Da): 52844 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128776)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G45730 | eukaryotic initiation factor 3 gamma subunit family protein |
Babesia bovis | BBOV_IV009810 | initiation factor 3 gamma subunit containing protein |
Brugia malayi | Bm1_28855 | Eukaryotic initiation factor 3, gamma subunit family protein |
Candida albicans | CaO19.500 | similar to S. cerevisiae GCD10 (YNL062C) tRNA(1-methyladenosine) methyltransferase subunit, translational repressor of GCN4 |
Candida albicans | CaO19.8130 | similar to S. cerevisiae GCD10 (YNL062C) tRNA(1-methyladenosine) methyltransferase subunit, translational repressor of GCN4 |
Caenorhabditis elegans | CELE_ZK858.7 | Protein ZK858.7 |
Dictyostelium discoideum | DDB_G0281175 | tRNA (adenine-N(1)-)-methyltransferase non-catalytic subunit |
Drosophila melanogaster | Dmel_CG9596 | CG9596 gene product from transcript CG9596-RC |
Echinococcus granulosus | EgrG_000106300 | tRNA adenine N1 methyltransferase |
Entamoeba histolytica | EHI_085970 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000106300 | tRNA (adenine N(1)) methyltransferase |
Homo sapiens | ENSG00000089195 | tRNA methyltransferase 6 |
Leishmania braziliensis | LbrM.35.6060 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_366030.1 | Gcd10p family, putative |
Leishmania infantum | LinJ.36.6030 | hypothetical protein, conserved |
Leishmania major | LmjF.36.5780 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.5780 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_09077 | eukaryotic initiation factor 3 |
Mus musculus | ENSMUSG00000037376 | tRNA methyltransferase 6 |
Neospora caninum | NCLIV_023490 | hypothetical protein, conserved |
Oryza sativa | 4334938 | Os04g0112300 |
Onchocerca volvulus | OVOC8152 |
|
Saccharomyces cerevisiae | YNL062C | Gcd10p |
Schistosoma japonicum | Sjp_0210460 | ko:K03256 translation initiation factor eIF-3 subunit P62, putative |
Schistosoma japonicum | Sjp_0317490 | IPR007316,Eukaryotic initiation factor 3, gamma subunit,domain-containing |
Schistosoma mansoni | Smp_012860 | translation initiation factor eif3-related |
Schmidtea mediterranea | mk4.002395.08 | tRNA |
Trypanosoma brucei gambiense | Tbg972.10.11040 | hypothetical protein, conserved |
Trypanosoma brucei | Tb11.v5.0508 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.9020 | Gcd10p family, putative |
Trypanosoma congolense | TcIL3000_10_7800 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.504171.30 | Gcd10p family, putative |
Trypanosoma cruzi | TcCLB.509795.30 | Gcd10p family, putative |
Toxoplasma gondii | TGME49_281545 | eukaryotic initiation factor 3, gamma subunit protein |
Theileria parva | TP01_0787 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.9020 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.9020 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.9020 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.9020 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_ZK858.7 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_ZK858.7 | Caenorhabditis elegans | slow growth | wormbase |
YNL062C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_281545 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.